Bank of America
CNTA

Bank of America’s Centessa Pharmaceuticals CNTA Stock Holding History

Bank of America’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.8M Buy
1,932,406
+982,862
+104% +$25.1M 0.01% 1309
2025
Q4 		$23.7M Buy
949,544
+396,537
+72% +$10M ﹤0.01% 2146
2025
Q3 		$13.4M Buy
553,007
+417,209
+307% +$7.42M ﹤0.01% 3002
2025
Q2 		$1.78M Sell
135,798
-71,230
-34% -$902K ﹤0.01% 4878
2025
Q1 		$2.98M Buy
207,028
+163,320
+374% +$2.67M ﹤0.01% 4317
2024
Q4 		$732K Sell
43,708
-269,630
-86% -$4.47M ﹤0.01% 5274
2024
Q3 		$5.01M Buy
313,338
+240,061
+328% +$2.94M ﹤0.01% 3730
2024
Q2 		$662K Sell
73,277
-3,707
-5% -$35.2K ﹤0.01% 5163
2024
Q1 		$870K Buy
76,984
+39,954
+108% +$378K ﹤0.01% 5011
2023
Q4 		$295K Sell
37,030
-14,913
-29% -$100K ﹤0.01% 5843
2023
Q3 		$336K Buy
51,943
+47,732
+1,134% +$327K ﹤0.01% 5585
2023
Q2 		$26.1K Buy
4,211
+2,926
+228% +$13.9K ﹤0.01% 6645
2023
Q1 		$4.95K Sell
1,285
-707
-35% -$2.59K ﹤0.01% 7073
2022
Q4 		$6.17K Buy
1,992
+1,826
+1,100% +$6.77K ﹤0.01% 7025
2022
Q3 		$0 Sell
166
-5,880
-97% -$26.9K ﹤0.01% 7875
2022
Q2 		$29K Sell
6,046
-38,131
-86% -$244K ﹤0.01% 7051
2022
Q1 		$396K Sell
44,177
-35,068
-44% -$320K ﹤0.01% 5994
2021
Q4 		$892K Buy
79,245
+76,446
+2,731% +$1.03M ﹤0.01% 5399
2021
Q3 		$46K Buy
2,799
+401
+17% +$8.3K ﹤0.01% 7082
2021
Q2 		$54K Buy
+2,398
New +$56.4K ﹤0.01% 6798

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bank of America's CNTA Position: Q1 2026 in Review

Bank of America increased its Centessa Pharmaceuticals (CNTA) stake by 104% in Q1 2026, buying an estimated $25.1M and bringing the position to 1,932,406 shares worth $76.8M. The position accounts for 0.01% of the portfolio, ranked #1309.

Bank of America first reported a position in CNTA in Q2 2021 and has held it in 20 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Bank of America held 1,932,406 shares of Centessa Pharmaceuticals worth $76.8M as of Q1 2026.
  • Bank of America bought 982,862 Centessa Pharmaceuticals shares in Q1 2026, an estimated $25.1M.
  • Centessa Pharmaceuticals made up 0.01% of Bank of America's portfolio in Q1 2026, its #1309 holding.
  • Bank of America first reported a position in Centessa Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.